3.6533
Mdxhealth Sa stock is traded at $3.6533, with a volume of 71,884.
It is up +2.91% in the last 24 hours and down -23.25% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$3.55
Open:
$3.52
24h Volume:
71,884
Relative Volume:
0.34
Market Cap:
$180.83M
Revenue:
$63.69M
Net Income/Loss:
$-44.82M
P/E Ratio:
-1.8267
EPS:
-2
Net Cash Flow:
$-30.56M
1W Performance:
-0.46%
1M Performance:
-23.25%
6M Performance:
+70.71%
1Y Performance:
+82.67%
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MDXH
Mdxhealth Sa
|
3.6533 | 175.72M | 63.69M | -44.82M | -30.56M | -2.00 |
|
TMO
Thermo Fisher Scientific Inc
|
575.24 | 218.08B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.13 | 161.37B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
717.35 | 57.97B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.32 | 42.25B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
224.92 | 38.70B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | Craig Hallum | Buy |
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
MDXH: Upcoming Virtual Meeting Hosted by BTIG - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough - simplywall.st
MDxHealth SA's (NASDAQ:MDXH) market cap touched US$182m last week, benefiting both individual investors who own 46% as well as institutions - simplywall.st
Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the most - Yahoo Finance
123,546 Shares in MDxHealth SA $MDXH Purchased by FreeGulliver LLC - MarketBeat
Is MDxHealth SA a good long term investmentEarnings Per Share Trends & Free Robust Financial Gains - earlytimes.in
How MDxHealth SA stock reacts to global recession fearsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Will MDxHealth SA stock rally after Fed decisions2025 Short Interest & Growth Focused Entry Point Reports - newser.com
MDxHealth (MDXH) Q3 2025 Earnings Call Transcript - AOL.com
What does recent volatility data suggest for MDxHealth SAWeekly Risk Summary & Reliable Volume Spike Trade Alerts - newser.com
Live market analysis of MDxHealth SA2025 Retail Activity & Low Risk Entry Point Tips - newser.com
How MDxHealth SA stock benefits from global expansionBull Run & Growth-Oriented Investment Plans - newser.com
How to monitor MDxHealth SA with trend dashboardsJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
Will MDxHealth SA stock deliver strong dividend growthChart Signals & Entry Point Confirmation Alerts - newser.com
FY2025 EPS Estimates for MDxHealth Reduced by William Blair - Defense World
OC500 2025: MICHAEL MCGARRITY - Orange County Business Journal
Volume spikes in MDxHealth SA stock – what they meanJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Market reaction to MDxHealth SA’s recent news2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
MDxHealth (NASDAQ:MDXH) Price Target Raised to $7.00 - Defense World
MDxHealth price target raised to $7 from $6 at BTIG - MSN
Mdxhealth S.A. Reports Strong Q3 Growth and Strategic Acquisition - MSN
MDxHealth price target raised to $9 from $7 at Lake Street - MSN
MDxHealth S.A. (NASDAQ:MDXH) Q3 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Can a trend reversal in MDxHealth SA lead to recoveryWeekly Market Summary & Daily Growth Stock Tips - newser.com
Can MDxHealth SA stock deliver strong Q4 earningsWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
Mdxhealth S.A. Earnings Call: Strategic Shifts Amid Growth - TipRanks
MDXH: Analyst Boosts Price Target Highlighting Strong Buy Recomm - GuruFocus
MDXH: Lake Street Raises Price Target on MDxHealth, Reaffirms Bu - GuruFocus
MDxHealth price target raised to $7 from $5 at TD Cowen - TipRanks
MDxHealth stock price target raised to $7 from $6 at BTIG on growth outlook - Investing.com Nigeria
Mdxhealth Q3 2025 revenue up 18% to USD 27.4M - Medical Buyer
MDxHealth ADR earnings missed by $0.05, revenue fell short of estimates - Investing.com Australia
MDXH Analyst Forecasts - Quiver Quantitative
MDXH Stock: BTIG Raises Price Target to $7 with 'Buy' Rating | M - GuruFocus
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):